Adenoviral expression of a bispecific VHH-based neutralizing agent that targets protective antigen provides prophylactic protection from anthrax in mice

Authors

Mahtab Moayeri, National Institutes of Health
Jacqueline M. Tremblay, Tufts University
Michelle Debatis, Tufts University
Igor P. Dmitriev, Washington University School of Medicine in St. Louis
Elena A. Kashentseva, Washington University School of Medicine in St. Louis
Anthony J. Yeh, National Institutes of Health
Gordon Y.C. Cheung, National Institutes of Health
David T. Curiel, Washington University School of Medicine in St. Louis
Stephen Leppla, National Institutes of Health
Charles B. Shoemaker, Tufts University

Journal

Clinical and Vaccine Immunology

Publication Date

2016

Volume

23

Issue

3

Inclusive Pages

213-218

Document Type

Open Access Publication

DOI

10.1128/CVI.00611-15

Rights and Permissions

Moayeri M, Tremblay JM, Debatis M, Dmitriev IP, Kashentseva EA, Yeh AJ, Cheung GYC, Curiel DT, Leppla S, Shoemaker CB. 2016. Adenoviral expression of a bispecific VHH-based neutralizing agent that targets protective antigen provides prophylactic protection from anthrax in mice. Clin Vaccine Immunol 23:213–218. doi:10.1128/CVI.00611-15.

Recommended Citation

Moayeri, Mahtab; Tremblay, Jacqueline M.; Debatis, Michelle; Dmitriev, Igor P.; Kashentseva, Elena A.; Yeh, Anthony J.; Cheung, Gordon Y.C.; Curiel, David T.; Leppla, Stephen; and Shoemaker, Charles B., "Adenoviral expression of a bispecific VHH-based neutralizing agent that targets protective antigen provides prophylactic protection from anthrax in mice." Clinical and Vaccine Immunology. 23, 3. 213-218. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/4875